메뉴 건너뛰기




Volumn 32, Issue 18, 2011, Pages 2247-2255

Blood pressure, lipids and glucose in type 2 diabetes: How low should we go? Re-discovering personalized care

Author keywords

Blood pressure; Cardiovascular risk; Diabetes; Glucose; Lipids; Target level

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ATORVASTATIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FENOFIBRATE; GLICLAZIDE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INDAPAMIDE PLUS PERINDOPRIL; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; NATEGLINIDE; PRAVASTATIN; ROSIGLITAZONE; SIMVASTATIN; TRIACYLGLYCEROL; VALSARTAN;

EID: 80052890774     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehr154     Document Type: Review
Times cited : (46)

References (98)
  • 2
    • 65349085059 scopus 로고    scopus 로고
    • Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham Heart Study, 1950 to 2005
    • Preis SR, Hwang SJ, Coady S, Pencina MJ, D'Agostino RB Sr, Savage PJ, Levy D, Fox CS. Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham Heart Study, 1950 to 2005. Circulation 2009;119:1728-1735.
    • (2009) Circulation , vol.119 , pp. 1728-1735
    • Preis, S.R.1    Hwang, S.J.2    Coady, S.3    Pencina, M.J.4    D'Agostino Sr., R.B.5    Savage, P.J.6    Levy, D.7    Fox, C.S.8
  • 6
    • 0027406191 scopus 로고
    • Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the multiple risk factor intervention trial
    • Stamler J, Vaccaro O, Neaton JD,Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993;16:434-444. (Pubitemid 23046633)
    • (1993) Diabetes Care , vol.16 , Issue.2 , pp. 434-444
    • Stamler, J.1    Vaccaro, O.2    Neaton, J.D.3    Wentworth, D.4
  • 14
    • 69149095761 scopus 로고    scopus 로고
    • ESH/ESC Guidelines for the management of hypertension, from theory to practice: Global cardiovascular risk concept
    • Volpe M, Tocci G. 2007 ESH/ESC Guidelines for the management of hypertension, from theory to practice: global cardiovascular risk concept. J Hypertens Suppl 2009;27:S3-S11.
    • (2007) J Hypertens Suppl 2009 , vol.27
    • Volpe, M.1    Tocci, G.2
  • 15
    • 33744828023 scopus 로고    scopus 로고
    • Global Guideline for Type 2 Diabetes: Recommendations for standard, comprehensive, and minimal care
    • IDF Clinical Guidelines Task Force
    • IDF Clinical Guidelines Task Force. Global Guideline for Type 2 Diabetes: recommendations for standard, comprehensive, and minimal care. Diabet Med 2006;23:579-593.
    • (2006) Diabet Med , vol.23 , pp. 579-593
  • 18
    • 58149301489 scopus 로고    scopus 로고
    • Intensive glycemic control and the prevention of cardiovascular events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials: A position statement of the American Diabetes Association and a Scientific Statement of the American College of Cardiology Foundation and the American Heart Association
    • Skyler JS, Bergenstal R, Bonow RO, Buse J, Deedwania P, Gale EA, Howard BV, Kirkman MS, Kosiborod M, Reaven P, Sherwin RS. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA Diabetes Trials: a position statement of the American Diabetes Association and a Scientific Statement of the American College of Cardiology Foundation and the American Heart Association. J Am Coll Cardiol 2009;53: 298-304.
    • (2009) J Am Coll Cardiol , vol.53 , pp. 298-304
    • Skyler, J.S.1    Bergenstal, R.2    Bonow, R.O.3    Buse, J.4    Deedwania, P.5    Gale, E.A.6    Howard, B.V.7    Kirkman, M.S.8    Kosiborod, M.9    Reaven, P.10    Sherwin, R.S.11
  • 19
    • 75149180515 scopus 로고    scopus 로고
    • Standards of medical care in diabetes-2010
    • Diabetes Association
    • Diabetes Association. Standards of medical care in diabetes-2010. Diabetes Care 2010;33(Suppl 1):S11-S61.
    • (2010) Diabetes Care , vol.33 , Issue.SUPPL. 1
  • 21
    • 33644810298 scopus 로고    scopus 로고
    • JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice
    • British Cardiac Society; British Hypertension Society; Diabetes UK; HEART UK; Primary Care Cardiovascular Society; Stroke Association
    • British Cardiac Society; British Hypertension Society; Diabetes UK; HEART UK; Primary Care Cardiovascular Society; Stroke Association. JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice. Heart 2005;91(Suppl 5):v1-v52.
    • (2005) Heart , vol.91 , Issue.SUPPL. 5
  • 25
    • 0037079309 scopus 로고    scopus 로고
    • Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies
    • DOI 10.1016/S0140-6736(02)11911-8
    • Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360:1903-1913. (Pubitemid 35472129)
    • (2002) Lancet , vol.360 , Issue.9349 , pp. 1903-1913
    • Lewington, S.1    Clarke, R.2    Qizilbash, N.3    Peto, R.4    Collins, R.5
  • 26
    • 0032511580 scopus 로고    scopus 로고
    • Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
    • United Kingdom Prospective Diabetes Study Group
    • United Kingdom Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998;317:703-713.
    • (1998) BMJ , vol.317 , pp. 703-713
  • 27
    • 0032511601 scopus 로고    scopus 로고
    • Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39
    • United Kingdom Prospective Diabetes Study Group
    • United Kingdom Prospective Diabetes Study Group. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. BMJ 1998;317:713-720.
    • (1998) BMJ , vol.317 , pp. 713-720
  • 28
    • 0034074955 scopus 로고    scopus 로고
    • Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes
    • Estacio RO, Jeffers BW, Gifford N, Schrier RW. Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes. Diabetes Care 2000;23(Suppl 2):B54-B64. (Pubitemid 30185779)
    • (2000) Diabetes Care , vol.23 , Issue.SUPPL. 2
    • Estacio, R.O.1    Jeffers, B.W.2    Gifford, N.3    Schrier, R.W.4
  • 29
    • 0036190137 scopus 로고    scopus 로고
    • Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes
    • DOI 10.1046/j.1523-1755.2002.00213.x
    • Schrier RW, Estacio RO, Esler A, Mehler P. Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes. Kidney Int 2002;61:1086-1097. (Pubitemid 34175478)
    • (2002) Kidney International , vol.61 , Issue.3 , pp. 1086-1097
    • Schrier, R.W.1    Estacio, R.O.2    Esler, A.3    Mehler, P.4
  • 30
    • 0032513878 scopus 로고    scopus 로고
    • Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial
    • DOI 10.1016/S0140-6736(98)04311-6
    • Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Julius S, Menard J, Rahn KH, Wedel H, Westerling S. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 1998;351:1755-1762. (Pubitemid 28269185)
    • (1998) Lancet , vol.351 , Issue.9118 , pp. 1755-1762
    • Hansson, L.1    Zanchetti, A.2    Carruthers, S.G.3    Dahlof, B.4    Elmfeldt, D.5    Julius, S.6    Menard, J.7    Rahn, K.H.8    Wedel, H.9    Westerling, S.10
  • 31
    • 0038708274 scopus 로고    scopus 로고
    • Benefits and risks of more intensive blood pressure lowering in hypertensive patients of the HOT study with different risk profiles: Does a J-shaped curve exist in smokers?
    • DOI 10.1097/00004872-200304000-00024
    • Zanchetti A, Hansson L, Clement D, Elmfeldt D, Julius S, Rosenthal T, Waeber B, Wedel H. Benefits and risks of more intensive blood pressure lowering in hypertensive patients of the HOT study with different risk profiles: does a J-shaped curve exist in smokers? J Hypertens 2003;21:797-804. (Pubitemid 36549676)
    • (2003) Journal of Hypertension , vol.21 , Issue.4 , pp. 797-804
    • Zanchetti, A.1    Hansson, L.2    Clement, D.3    Elmfeldt, D.4    Julius, S.5    Rosenthal, T.6    Waeber, B.7    Wedel, H.8
  • 35
    • 0034700790 scopus 로고    scopus 로고
    • Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: Results of the HOPE study and MICRO-HOPE substudy
    • Heart Outcomes Prevention Evaluation Study Investigators
    • Heart Outcomes Prevention Evaluation Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet 2000;355: 253-259.
    • (2000) Lancet , vol.355 , pp. 253-259
  • 38
    • 0035922444 scopus 로고    scopus 로고
    • The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes
    • Parving HH, Lehnert H, Brochner-Mortensen J, Gomis R, Andersen S, Arner P. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med 2001;345:870-878.
    • (2001) N Engl J Med , vol.345 , pp. 870-878
    • Parving, H.H.1    Lehnert, H.2    Brochner-Mortensen, J.3    Gomis, R.4    Andersen, S.5    Arner, P.6
  • 42
    • 34548420712 scopus 로고    scopus 로고
    • Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): A randomised controlled trial
    • DOI 10.1016/S0140-6736(07)61303-8, PII S0140673607613038
    • Patel A, MacMahon S, Chalmers J, Neal B, Woodward M, Billot L, Harrap S, Poulter N, Marre M, Cooper M, Glasziou P, Grobbee DE, Hamet P, Heller S, Liu LS, Mancia G, Mogensen CE, Pan CY, Rodgers A, Williams B. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet 2007;370:829-840. (Pubitemid 47362321)
    • (2007) Lancet , vol.370 , Issue.9590 , pp. 829-840
    • Patel, A.1
  • 44
    • 67649651744 scopus 로고    scopus 로고
    • When should antihypertensive drug treatment be initiated and to what levels should systolic blood pressure be lowered? A critical reappraisal
    • Zanchetti A, Grassi G, Mancia G. When should antihypertensive drug treatment be initiated and to what levels should systolic blood pressure be lowered? A critical reappraisal. J Hypertens 2009;27:923-934.
    • (2009) J Hypertens , vol.27 , pp. 923-934
    • Zanchetti, A.1    Grassi, G.2    Mancia, G.3
  • 45
    • 77956632368 scopus 로고    scopus 로고
    • Effects of intensive blood pressure control in the management of patients with type 2 diabetes mellitus in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial
    • Mancia G. Effects of intensive blood pressure control in the management of patients with type 2 diabetes mellitus in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Circulation 2010;122:847-849.
    • (2010) Circulation , vol.122 , pp. 847-849
    • Mancia, G.1
  • 47
    • 70350440515 scopus 로고    scopus 로고
    • The J-curve between blood pressure and coronary artery disease or essential hypertension: Exactly how essential?
    • Messerli FH, Panjrath GS. The J-curve between blood pressure and coronary artery disease or essential hypertension: exactly how essential? J Am Coll Cardiol 2009;54:1827-1834.
    • (2009) J Am Coll Cardiol , vol.54 , pp. 1827-1834
    • Messerli, F.H.1    Panjrath, G.S.2
  • 49
    • 73849098313 scopus 로고    scopus 로고
    • Outcomes among hypertensive patients with concomitant peripheral and coronary artery disease: Findings from the INternational VErapamil-SR/ Trandolapril STudy
    • Bavry AA, Anderson RD, Gong Y, Denardo SJ, Cooper-Dehoff RM, Handberg EM, Pepine CJ. Outcomes Among hypertensive patients with concomitant peripheral and coronary artery disease: findings from the INternational VErapamil-SR/ Trandolapril STudy. Hypertension 2010;55:48-53.
    • (2010) Hypertension , vol.55 , pp. 48-53
    • Bavry, A.A.1    Anderson, R.D.2    Gong, Y.3    Denardo, S.J.4    Cooper-Dehoff, R.M.5    Handberg, E.M.6    Pepine, C.J.7
  • 50
    • 66849131593 scopus 로고    scopus 로고
    • Ischemic stroke in South Asians: A review of the epidemiology, pathophysiology, and ethnicity-related clinical features
    • Gunarathne A, Patel JV, Gammon B, Gill PS, Hughes EA, Lip GY. Ischemic stroke in South Asians: a review of the epidemiology, pathophysiology, and ethnicity-related clinical features. Stroke 2009;40:e415-e423.
    • (2009) Stroke , vol.40
    • Gunarathne, A.1    Patel, J.V.2    Gammon, B.3    Gill, P.S.4    Hughes, E.A.5    Lip, G.Y.6
  • 51
    • 22144477948 scopus 로고    scopus 로고
    • Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: Results of prospectively designed overviews of randomized trials
    • DOI 10.1001/archinte.165.12.1410
    • Turnbull F, Neal B, Algert C, Chalmers J, Chapman N, Cutler J, Woodward M, MacMahon S. Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials. Arch Intern Med 2005; 165:1410-1419. (Pubitemid 40973424)
    • (2005) Archives of Internal Medicine , vol.165 , Issue.12 , pp. 1410-1419
    • Turnbull, F.1
  • 52
    • 27844563671 scopus 로고    scopus 로고
    • Antihypertensive therapy in diabetes mellitus: Insights from ALLHAT and the Blood Pressure-Lowering Treatment Trialists' Collaboration meta-analysis
    • DOI 10.1038/sj.jhh.1001926, PII 1001926
    • Varughese GI, Lip GY. Antihypertensive therapy in diabetes mellitus: insights from ALLHAT and the Blood Pressure-Lowering Treatment Trialists' Collaboration meta-analysis. J Hum Hypertens 2005;19:851-853. (Pubitemid 41637600)
    • (2005) Journal of Human Hypertension , vol.19 , Issue.11 , pp. 851-853
    • Varughese, G.I.1    Lip, G.Y.H.2
  • 53
    • 0344373794 scopus 로고    scopus 로고
    • Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
    • and Coordinators for the ALLHAT Collaborative Research Group
    • ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002;288:2981-2997.
    • (2002) JAMA , vol.288 , pp. 2981-2997
    • Officers, A.1
  • 54
    • 34548392359 scopus 로고    scopus 로고
    • Vascular outcome in type 2 diabetes: an ADVANCE?
    • DOI 10.1016/S0140-6736(07)61304-X, PII S014067360761304X
    • Kaplan NM. Vascular outcome in type 2 diabetes: an ADVANCE? Lancet 2007; 370:804-805. (Pubitemid 47362322)
    • (2007) Lancet , vol.370 , Issue.9590 , pp. 804-805
    • Kaplan, N.M.1
  • 55
    • 77957674852 scopus 로고    scopus 로고
    • Cost-effectiveness of lowering blood pressure with a fixed combination of perindopril and indapamide in type 2 diabetes mellitus: An ADVANCE trial-based analysis
    • Glasziou PP, Clarke P, Alexander J, Rajmokan M, Beller E, Woodward M, Chalmers J, Poulter N, Patel A. Cost-effectiveness of lowering blood pressure with a fixed combination of perindopril and indapamide in type 2 diabetes mellitus: an ADVANCE trial-based analysis. Med J Aust 2010;193:320-324.
    • (2010) Med J Aust , vol.193 , pp. 320-324
    • Glasziou, P.P.1    Clarke, P.2    Alexander, J.3    Rajmokan, M.4    Beller, E.5    Woodward, M.6    Chalmers, J.7    Poulter, N.8    Patel, A.9
  • 59
    • 0034732256 scopus 로고    scopus 로고
    • Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus
    • DOI 10.1056/NEJM200003303421301
    • Gress TW, Nieto FJ, Shahar E, Wofford MR, Brancati FL. Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study. N Engl J Med 2000;342:905-912. (Pubitemid 30177050)
    • (2000) New England Journal of Medicine , vol.342 , Issue.13 , pp. 905-912
    • Gress, T.W.1    Nieto, F.J.2    Shahar, E.3    Wofford, M.R.4    Brancati, F.L.5
  • 60
    • 77950511412 scopus 로고    scopus 로고
    • Executive summary: Standards of medical care in diabetes-2010
    • American Diabetes Association
    • American Diabetes Association. Executive summary: standards of medical care in diabetes-2010. Diabetes Care 2010;33(Suppl 1):S4-S10.
    • (2010) Diabetes Care , vol.33 , Issue.SUPPL. 1
  • 61
    • 0029147687 scopus 로고
    • Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: A randomized prospective 6-year study
    • Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, Kojima Y, Furuyoshi N, Shichiri M. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 1995;28:103-117.
    • (1995) Diabetes Res Clin Pract , vol.28 , pp. 103-117
    • Ohkubo, Y.1    Kishikawa, H.2    Araki, E.3    Miyata, T.4    Isami, S.5    Motoyoshi, S.6    Kojima, Y.7    Furuyoshi, N.8    Shichiri, M.9
  • 62
    • 0032511583 scopus 로고    scopus 로고
    • Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
    • United Kingdom Prospective Diabetes Study Group
    • United Kingdom Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-853.
    • (1998) Lancet , vol.352 , pp. 837-853
  • 63
    • 0031018291 scopus 로고    scopus 로고
    • Cardiovascular events and correlates in the Veterans Affairs diabetes feasibility trial: Veterans Affairs cooperative study on glycemic control and complications in type II diabetes
    • Abraira C, Colwell J, Nuttall F, Sawin CT, Henderson W, Comstock JP, Emanuele NV, Levin SR, Pacold I, Lee HS. Cardiovascular events and correlates in the Veterans Affairs Diabetes Feasibility Trial. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes. Arch Intern Med 1997;157:181-188. (Pubitemid 27058152)
    • (1997) Archives of Internal Medicine , vol.157 , Issue.2 , pp. 181-188
    • Abraira, C.1    Colwell, J.2    Nuttall, F.3    Sawin, C.T.4    Henderson, W.5    Comstock, J.P.6    Emanuele, N.V.7    Levin, S.R.8    Pacold, I.9    Lee, H.S.10
  • 64
    • 0014914649 scopus 로고
    • A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality results
    • Meinert CL, Knatterud GL, Prout TE, Klimt CR. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality results. Diabetes 1970;19(suppl):789-830.
    • (1970) Diabetes , vol.19 , Issue.SUPPL. , pp. 789-830
    • Meinert, C.L.1    Knatterud, G.L.2    Prout, T.E.3    Klimt, C.R.4
  • 65
    • 0032511566 scopus 로고    scopus 로고
    • Effect of intensive bloodglucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)
    • United Kingdom Prospective Diabetes Study Group
    • United Kingdom Prospective Diabetes Study Group. Effect of intensive bloodglucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998;352:854-865.
    • (1998) Lancet , vol.352 , pp. 854-865
  • 69
    • 80052873231 scopus 로고    scopus 로고
    • Oral presentation: Update on epidemiologic research to explain the higher mortality in the intensive glycaemic control arm of the ACCORD trial. Interest group discussion on epidemiology and statistics
    • Orlando, FL, USA
    • Lachin JM. Oral presentation: update on epidemiologic research to explain the higher mortality in the intensive glycaemic control arm of the ACCORD trial. Interest group discussion on epidemiology and statistics. American Diabetes Association 70th scientific sessions. Orlando, FL, USA; 2010.
    • (2010) American Diabetes Association 70th Scientific Sessions
    • Lachin, J.M.1
  • 73
    • 77649205993 scopus 로고    scopus 로고
    • Glycated haemoglobin below 7% No to QOF target of less than 7%, again
    • Lehman R, Krumholz HM. Glycated haemoglobin below 7%. No to QOF target of less than 7%, again. BMJ 2010;340:c985.
    • (2010) BMJ , vol.340
    • Lehman, R.1    Krumholz, H.M.2
  • 76
    • 0037840242 scopus 로고    scopus 로고
    • MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: A randomised placebo-controlled trial
    • Collins R, Armitage J, Parish S, Sleigh P, Peto R. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet 2003;361:2005-2016.
    • (2003) Lancet , vol.361 , pp. 2005-2016
    • Collins, R.1    Armitage, J.2    Parish, S.3    Sleigh, P.4    Peto, R.5
  • 77
    • 4344683381 scopus 로고    scopus 로고
    • Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): Multicentre randomised placebo-controlled trial
    • DOI 10.1016/S0140-6736(04)16895-5, PII S0140673604168955
    • Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HA, Livingstone SJ, Thomason MJ, Mackness MI, Charlton-Menys V, Fuller JH. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebocontrolled trial. Lancet 2004;364:685-696. (Pubitemid 39140624)
    • (2004) Lancet , vol.364 , Issue.9435 , pp. 685-696
    • Colhoun, H.M.1    Betteridge, D.J.2    Durrington, P.N.3    Hitman, G.A.4    Neil, H.A.W.5    Livingstone, S.J.6    Thomason, M.J.7    Mackness, M.I.8    Charlton-Menys, V.9    Fuller, J.H.10
  • 78
    • 33749015458 scopus 로고    scopus 로고
    • Acute coronary syndromes and diabetes: Is intensive lipid lowering beneficial? Results of the PROVE IT-TIMI 22 trial
    • DOI 10.1093/eurheartj/ehl220
    • Ahmed S, Cannon CP, Murphy SA, Braunwald E. Acute coronary syndromes and diabetes: Is intensive lipid lowering beneficial? Results of the PROVE IT-TIMI 22 trial. Eur Heart J 2006;27:2323-2329. (Pubitemid 44453576)
    • (2006) European Heart Journal , vol.27 , Issue.19 , pp. 2323-2329
    • Ahmed, S.1    Cannon, C.P.2    Murphy, S.A.3    Braunwald, E.4
  • 81
    • 64749095070 scopus 로고    scopus 로고
    • Effects of fenofibrate treatment on cardiovascular disease risk in 9,795 individuals with type 2 diabetes and various components of the metabolic syndrome: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study
    • Scott R, O'Brien R, Fulcher G, Pardy C, D'Emden M, Tse D, Taskinen MR, Ehnholm C, Keech A. Effects of fenofibrate treatment on cardiovascular disease risk in 9,795 individuals with type 2 diabetes and various components of the metabolic syndrome: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. Diabetes Care 2009;32:493-498.
    • (2009) Diabetes Care , vol.32 , pp. 493-498
    • Scott, R.1    O'Brien, R.2    Fulcher, G.3    Pardy, C.4    D'Emden, M.5    Tse, D.6    Taskinen, M.R.7    Ehnholm, C.8    Keech, A.9
  • 82
    • 0037049366 scopus 로고    scopus 로고
    • Diabetes, plasma insulin, and cardiovascular disease: Subgroup analysis from the Department of Veterans Affairs High-density Lipoprotein Intervention Trial (VA-HIT)
    • DOI 10.1001/archinte.162.22.2597
    • Rubins HB, Robins SJ, Collins D, Nelson DB, Elam MB, Schaefer EJ, Faas FH, Anderson JW. Diabetes, plasma insulin, and cardiovascular disease: subgroup analysis from the Department of Veterans Affairs High-Density Lipoprotein Intervention Trial (VA-HIT). Arch Intern Med 2002;162:2597-2604. (Pubitemid 35453499)
    • (2002) Archives of Internal Medicine , vol.162 , Issue.22 , pp. 2597-2604
    • Rubins, H.B.1    Robins, S.J.2    Collins, D.3    Nelson, D.B.4    Elam, M.B.5    Schaefer, E.J.6    Faas, F.H.7    Anderson, J.W.8
  • 83
    • 0023232216 scopus 로고
    • Helsinki Heart Study: Primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease
    • Frick MH, Elo O, Haapa K, Heinonen OP, Heinsalmi P, Helo P, Huttunen JK, Kaitaniemi P, Koskinen P, Manninen V et al. Helsinki Heart Study: primaryprevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med 1987;317:1237-1245. (Pubitemid 17147964)
    • (1987) New England Journal of Medicine , vol.317 , Issue.20 , pp. 1237-1245
    • Frick, M.H.1    Elo, O.2    Haapa, K.3
  • 84
    • 0034604225 scopus 로고    scopus 로고
    • Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease: The Bezafibrate Infarction Prevention (BIP) study
    • The Bezafibrate Infarction Prevention Study Group
    • The Bezafibrate Infarction Prevention Study Group. Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease: the Bezafibrate Infarction Prevention (BIP) study. Circulation 2000;102:21-27.
    • (2000) Circulation , vol.102 , pp. 21-27
  • 87
    • 0026597808 scopus 로고
    • Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment
    • Manninen V, Tenkanen L, Koskinen P, Huttunen JK, Manttari M, Heinonen OP, Frick MH. Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment. Circulation 1992;85:37-45.
    • (1992) Circulation , vol.85 , pp. 37-45
    • Manninen, V.1    Tenkanen, L.2    Koskinen, P.3    Huttunen, J.K.4    Manttari, M.5    Heinonen, O.P.6    Frick, M.H.7
  • 89
    • 77954178839 scopus 로고    scopus 로고
    • Variation in the net benefit of aggressive cardiovascular risk factor control across the US population of patients with diabetes mellitus
    • Timbie JW, Hayward RA, Vijan S. Variation in the net benefit of aggressive cardiovascular risk factor control across the US population of patients with diabetes mellitus. Arch Intern Med 2010;170:1037-1044.
    • (2010) Arch Intern Med , vol.170 , pp. 1037-1044
    • Timbie, J.W.1    Hayward, R.A.2    Vijan, S.3
  • 92
    • 77953414555 scopus 로고    scopus 로고
    • Diabetes connected health: A pilot study of a patient-and provider-shared glucose monitoring web application
    • Watson AJ, Kvedar JC, Rahman B, Pelletier AC, Salber G, Grant RW. Diabetes connected health: a pilot study of a patient-and provider-shared glucose monitoring web application. J Diabetes Sci Technol 2009;3:345-352.
    • (2009) J Diabetes Sci Technol , vol.3 , pp. 345-352
    • Watson, A.J.1    Kvedar, J.C.2    Rahman, B.3    Pelletier, A.C.4    Salber, G.5    Grant, R.W.6
  • 94
    • 67651156329 scopus 로고    scopus 로고
    • Individualized electronic decision support and reminders to improve diabetes care in the community: COMPETE II randomized trial
    • Holbrook A, Thabane L, Keshavjee K, Dolovich L, Bernstein B, Chan D, Troyan S, Foster G, Gerstein H. Individualized electronic decision support and reminders to improve diabetes care in the community: COMPETE II randomized trial. CMAJ 2009;181:37-44.
    • (2009) CMAJ , vol.181 , pp. 37-44
    • Holbrook, A.1    Thabane, L.2    Keshavjee, K.3    Dolovich, L.4    Bernstein, B.5    Chan, D.6    Troyan, S.7    Foster, G.8    Gerstein, H.9
  • 95
    • 0032585222 scopus 로고    scopus 로고
    • Randomised controlled trial of patient centred care of diabetes in general practice: Impact on current wellbeing and future disease risk
    • Kinmonth AL, Woodcock A, Griffin S, Spiegal N, Campbell MJ. Randomised controlled trial of patient centred care of diabetes in general practice: impact on current wellbeing and future disease risk. The Diabetes Care From Diagnosis Research Team. BMJ 1998;317:1202-1208. (Pubitemid 28488511)
    • (1998) British Medical Journal , vol.317 , Issue.7167 , pp. 1202-1208
    • Kinmonth, A.L.1    Woodcock, A.2    Griffin, S.3    Spiegal, N.4    Campbell, M.J.5
  • 96
    • 37849010633 scopus 로고    scopus 로고
    • Patientprovider interaction from the perspectives of type 2 diabetes patients in Muscat, Oman: A qualitative study
    • Abdulhadi N, Al Shafaee M, Freudenthal S, Ostenson CG, Wahlstrom R. Patientprovider interaction from the perspectives of type 2 diabetes patients in Muscat, Oman: a qualitative study. BMC Health Serv Res 2007;7:162.
    • (2007) BMC Health Serv Res , vol.7 , pp. 162
    • Abdulhadi, N.1    Al Shafaee, M.2    Freudenthal, S.3    Ostenson, C.G.4    Wahlstrom, R.5
  • 97
    • 34249911988 scopus 로고    scopus 로고
    • A multicenter randomized controlled trial of motivational interviewing in teenagers with diabetes
    • DOI 10.2337/dc06-2260
    • Channon SJ, Huws-Thomas MV, Rollnick S, Hood K, Cannings-John RL, Rogers C, Gregory JW. A multicenter randomized controlled trial of motivational interviewing in teenagers with diabetes. Diabetes Care 2007;30:1390-1395. (Pubitemid 46871143)
    • (2007) Diabetes Care , vol.30 , Issue.6 , pp. 1390-1395
    • Channon, S.J.1    Huws-Thomas, M.V.2    Rollnick, S.3    Hood, K.4    Cannings-John, R.L.5    Rogers, C.6    Gregory, J.W.7


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.